Three companies in the healthcare space have recently closed funding rounds, with VCs from the women’s & reproductive health ecosystem backing platforms ranging from fertility clinic software to personalized nutrition and hospital-at-home care.
FERT Secures $20 Million for Fertility Clinic EMR
MonCap has invested $20 million in FERT, an electronic medical records platform built for fertility clinics. The investment positions FERT as what MonCap describes as the best-capitalized EMR in the fertility industry.
FERT joins two other MonCap portfolio companies, EngagedMD and PatientFi, in what the firm calls its ‘Fertility Ecosystem’. The three platforms collectively serve approximately 70% of fertility patients in North America, according to MonCap.
The cloud-based platform handles cycle monitoring, outcomes analysis, and coordination for complex cases involving donors and surrogates. FERT has doubled its team size following the investment and plans to accelerate feature development and third-party integrations.
Rem3dy Health Raises £1.4 Million in Cross-Border Round
UK-based Rem3dy Health has closed £1.4 million in funding split between Amsterdam’s Borski Fund and the West Midlands Co-Investment Fund managed by Future Planet Capital Regional. The round marks Borski Fund’s first UK investment.
Borski Fund led with £900,000, followed by £500,000 from the regional co-investment fund. The funding brings Rem3dy Health’s total capital raised to £20 million.
Founded by Melissa Snover, Rem3dy Health produces personalized vitamin gummies using patented 3D printing technology under its Nourished brand.
“This latest round marks a huge milestone not just for Rem3dy Health, but for the Midlands innovation scene,” said Snover. “This investment proves that regional founders can raise global capital and scale globally from right here in Birmingham.”
The company plans to expand beyond vitamins into protein bars and pharmaceutical applications.
“From our first meeting, Melissa’s vision and drive towards realising Rem3dy Health’s global potential was unmissable,” said Jen Roberts-Woods, Investment Associate at Borski Fund.
SteelSky Ventures Backs Hospital-at-Home Platform myLaurel
SteelSky Ventures has led an undisclosed investment in myLaurel, joining existing backers Deerfield Management and Google Ventures. The funding will support national expansion of the company’s hospital-at-home acute care model.
myLaurel partners with health systems to deliver high-acuity care in patient homes using AI-powered coordination for logistics, documentation, and virtual physician oversight. The platform operates in New York City and New Orleans with partners including Ochsner Health, LCMC Health, and Maimonides Medical Center.
The company reports a 49% reduction in hospital readmissions and a 6-to-1 return on investment for hospital partners, alongside patient satisfaction scores above 90 NPS.
“myLaurel is transforming one of the most complex areas of healthcare delivery by creating a scalable, data-driven model for hospital-level care at home,” said Maria Toler, founding and managing partner at SteelSky Ventures, who joins myLaurel’s board.
